Pharmacists for Fair Reimbursement What your state's PBM laws actually mean for community pharmacies
State Tracker Updated June 15, 2026

Texas: what the PBM reimbursement law requires

Texas does not require NADAC-based or above-acquisition-cost reimbursement. It regulates how PBMs build and update maximum allowable cost (MAC) lists and gives pharmacies a 10-day MAC-price appeal — but it sets no reimbursement floor.

Status Partially enacted
Law Tex. Ins. Code ch. 1369, Subchapter H (§§ 1369.351–1369.357); SB 332 (2015), updated 2023 and 2025
Effective date MAC/appeal regime in effect since 2015
Reimbursement basis No reimbursement floor; MAC-list construction and update rules only
Professional dispensing fee Not specified in statute
Appeal route Pharmacy may appeal a MAC price on or before the 10th day after the claim; PBM must respond by the 10th day after receiving the appeal; a denied appeal must include an NDC showing where the drug is available at the MAC price

Texas regulates MAC lists, not reimbursement levels. The maximum allowable cost subchapter of the Insurance Code requires that a drug be listed only if it is a qualifying generic “generally available for purchase” from a Texas wholesaler, and that lists be updated — but it does not require reimbursement at NADAC or above acquisition cost.

Pharmacies get a defined appeal: a MAC price may be appealed on or before the 10th day after the claim, and the PBM must respond by the 10th day after receiving the appeal. On a denial, the PBM must identify an NDC showing where the drug is available at the disputed MAC price.

Sources

Back to the tracker